Justice Department Reclassifies Medical Marijuana in Historic Federal Policy Shift

Clear Facts

• Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed medical marijuana from Schedule I to Schedule III
• The change moves marijuana from the same classification as heroin to a category recognizing medicinal properties
• The reclassification applies specifically to state-licensed medical marijuana operations

The Trump administration delivered a significant shift in federal drug policy Thursday when Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana under federal law. The move represents a major departure from decades of federal drug enforcement policy.

Under the new classification, state-licensed medical marijuana moves from Schedule I—reserved for substances with no accepted medical use, including heroin—to Schedule III. Schedule III drugs are recognized as having accepted medical applications, placing marijuana in the same category as medications like ketamine and certain anabolic steroids.

The reclassification applies specifically to marijuana operations licensed under state medical programs. This targeted approach acknowledges the growing acceptance of medical marijuana across the United States while maintaining federal oversight.

The change comes as dozens of states have established medical marijuana programs, creating tension between state-level legalization efforts and federal prohibition. The rescheduling could ease certain restrictions on medical marijuana research and reduce legal conflicts between state-licensed operators and federal authorities.

The Justice Department’s decision marks one of the most substantial federal policy changes regarding marijuana in American history. For years, conservative and libertarian voices have called for states’ rights to be respected on this issue, arguing that federal overreach has prevented states from implementing their own approaches to medical treatment options.

The reclassification does not legalize marijuana at the federal level but recognizes its medical applications when administered through state-licensed programs. Federal law enforcement priorities may shift accordingly, though the full implications of the policy change remain to be seen.

Let us know what you think, please share your thoughts in the comments below.